Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
Sadoff, Jerald, Le Gars, Mathieu, Shukarev, Georgi, Heerwegh, Dirk, Truyers, Carla, de Groot, Anne M, Stoop, Jeroen, Tete, Sarah, Van Damme, Wim, Leroux-Roels, Isabel, Berghmans, Pieter-Jan, Kimmel, Murray, Van Damme, Pierre, de Hoon, Jan, Smith, William, Stephenson, Kathryn E, De Rosa, Stephen C, Cohen, Kristen W, McElrath, M. Juliana, Cormier, Emmanuel, Scheper, Gert, Barouch, Dan H, Hendriks, Jenny, Struyf, Frank, Douoguih, Macaya, Van Hoof, Johan, Schuitemaker, Hanneke
Published in New England Journal of Medicine (13.05.2021)
Published in New England Journal of Medicine (13.05.2021)
Get full text
Journal Article
Web Resource
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
Alter, Galit, Yu, Jingyou, Liu, Jinyan, Chandrashekar, Abishek, Borducchi, Erica N., Tostanoski, Lisa H., McMahan, Katherine, Jacob-Dolan, Catherine, Martinez, David R., Chang, Aiquan, Anioke, Tochi, Lifton, Michelle, Nkolola, Joseph, Stephenson, Kathryn E., Atyeo, Caroline, Shin, Sally, Fields, Paul, Kaplan, Ian, Robins, Harlan, Amanat, Fatima, Krammer, Florian, Baric, Ralph S., Le Gars, Mathieu, Sadoff, Jerald, de Groot, Anne Marit, Heerwegh, Dirk, Struyf, Frank, Douoguih, Macaya, van Hoof, Johan, Schuitemaker, Hanneke, Barouch, Dan H.
Published in Nature (London) (12.08.2021)
Published in Nature (London) (12.08.2021)
Get full text
Journal Article
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa
Barry, Houreratou, Mutua, Gaudensia, Kibuuka, Hannah, Anywaine, Zacchaeus, Sirima, Sodiomon B, Meda, Nicolas, Anzala, Omu, Eholie, Serge, Bétard, Christine, Richert, Laura, Lacabaratz, Christine, McElrath, M Juliana, De Rosa, Stephen, Cohen, Kristen W, Shukarev, Georgi, Robinson, Cynthia, Gaddah, Auguste, Heerwegh, Dirk, Bockstal, Viki, Luhn, Kerstin, Leyssen, Maarten, Douoguih, Macaya, Thiébaut, Rodolphe
Published in PLoS medicine (29.10.2021)
Published in PLoS medicine (29.10.2021)
Get full text
Journal Article
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine
Salisch, Nadine C, Stephenson, Kathryn E, Williams, Kristi, Cox, Freek, van der Fits, Leslie, Heerwegh, Dirk, Truyers, Carla, Habets, Marrit N, Kanjilal, Diane G, Larocca, Rafael A, Abbink, Peter, Liu, Jinyan, Peter, Lauren, Fierro, Carlos, De La Barrera, Rafael A, Modjarrad, Kayvon, Zahn, Roland C, Hendriks, Jenny, Cahill, Conor P, Leyssen, Maarten, Douoguih, Macaya, van Hoof, Johan, Schuitemaker, Hanneke, Barouch, Dan H
Published in Annals of internal medicine (01.05.2021)
Published in Annals of internal medicine (01.05.2021)
Get more information
Journal Article
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial
Anywaine, Zacchaeus, Barry, Houreratou, Anzala, Omu, Mutua, Gaudensia, Sirima, Sodiomon B, Eholie, Serge, Kibuuka, Hannah, Bétard, Christine, Richert, Laura, Lacabaratz, Christine, McElrath, M Juliana, De Rosa, Stephen C, Cohen, Kristen W, Shukarev, Georgi, Katwere, Michael, Robinson, Cynthia, Gaddah, Auguste, Heerwegh, Dirk, Bockstal, Viki, Luhn, Kerstin, Leyssen, Maarten, Thiébaut, Rodolphe, Douoguih, Macaya
Published in PLoS medicine (11.01.2022)
Published in PLoS medicine (11.01.2022)
Get full text
Journal Article
Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults
Ockenhouse, Christian F, Regules, Jason, Tosh, Donna, Cowden, Jessica, Kathcart, April, Cummings, James, Paolino, Kristopher, Moon, James, Komisar, Jack, Kamau, Edwin, Oliver, Thomas, Chhoeu, Austin, Murphy, Jitta, Lyke, Kirsten, Laurens, Matthew, Birkett, Ashley, Lee, Cynthia, Weltzin, Rich, Wille-Reece, Ulrike, Sedegah, Martha, Hendriks, Jenny, Versteege, Isabella, Pau, Maria Grazia, Sadoff, Jerold, Vanloubbeeck, Yannick, Lievens, Marc, Heerwegh, Dirk, Moris, Philippe, Guerra Mendoza, Yolanda, Jongert, Erik, Cohen, Joe, Voss, Gerald, Ballou, W Ripley, Vekemans, Johan
Published in PloS one (06.07.2015)
Published in PloS one (06.07.2015)
Get full text
Journal Article
Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial
Otieno, Lucas, Dr, Oneko, Martina, MD, Otieno, Walter, PhD, Abuodha, Joseph, MBChB, Owino, Emmanuel, MSc, Odero, Chris, PGD PH, Mendoza, Yolanda Guerra, MD, Andagalu, Ben, MSc, Awino, Norbert, MSc, Ivinson, Karen, BSc, Heerwegh, Dirk, PhD, Otsyula, Nekoye, MSc, Oziemkowska, Maria, MPH, Usuf, Effua Abigail, PhD, Otieno, Allan, MD, Otieno, Kephas, MPH, Leboulleux, Didier, MD, Leach, Amanda, MRCPCH, Oyieko, Janet, MD, Slutsker, Laurence, MD, Lievens, Marc, MSc, Cowden, Jessica, MD, Lapierre, Didier, MD, Kariuki, Simon, PhD, Ogutu, Bernhards, PhD, Vekemans, Johan, PhD, Hamel, Mary J, MD
Published in The Lancet infectious diseases (01.10.2016)
Published in The Lancet infectious diseases (01.10.2016)
Get full text
Journal Article
Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola
Bockstal, Viki, Leyssen, Maarten, Heerwegh, Dirk, Spiessens, Bart, Robinson, Cynthia, Stoop, Jeroen N., Roozendaal, Ramon, Van Effelterre, Thierry, Gaddah, Auguste, Van Roey, Griet A., Solforosi, Laura, Zahn, Roland, Callendret, Benoit, Hendriks, Jenny, Luhn, Kerstin, Douoguih, Macaya, Schuitemaker, Hanneke, Van Hoof, Johan
Published in npj vaccines (30.11.2022)
Published in npj vaccines (30.11.2022)
Get full text
Journal Article
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters
Tostanoski, Lisa H., Chandrashekar, Abishek, Patel, Shivani, Yu, Jingyou, Jacob-Dolan, Catherine, Chang, Aiquan, Powers, Olivia C., Sellers, Daniel, Gardner, Sarah, Barrett, Julia, Sanborn, Owen, Stephenson, Kathryn E., Ansel, Jessica L., Jaegle, Kate, Seaman, Michael S., Porto, Maciel, Lok, Megan, Spence, Brittany, Cayer, Kathleen, Nase, Danielle, Holman, Shaikim, Bradette, Heath, Kar, Swagata, Andersen, Hanne, Lewis, Mark G., Cox, Freek, Tolboom, Jeroen T. B. M., de Groot, Anne Marit, Heerwegh, Dirk, Le Gars, Mathieu, Sadoff, Jerald, Wegmann, Frank, Zahn, Roland C., Schuitemaker, Hanneke, Barouch, Dan H.
Published in npj vaccines (10.01.2022)
Published in npj vaccines (10.01.2022)
Get full text
Journal Article
Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
Barouch, Dan H, Stephenson, Kathryn E, Sadoff, Jerald, Yu, Jingyou, Chang, Aiquan, Gebre, Makda, McMahan, Katherine, Liu, Jinyan, Chandrashekar, Abishek, Patel, Shivani, Le Gars, Mathieu, de Groot, Anne M, Heerwegh, Dirk, Struyf, Frank, Douoguih, Macaya, van Hoof, Johan, Schuitemaker, Hanneke
Published in New England Journal of Medicine (02.09.2021)
Published in New England Journal of Medicine (02.09.2021)
Get full text
Journal Article
Web Resource
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
Stephenson, Kathryn E, Le Gars, Mathieu, Sadoff, Jerald, de Groot, Anne Marit, Heerwegh, Dirk, Truyers, Carla, Atyeo, Caroline, Loos, Carolin, Chandrashekar, Abishek, McMahan, Katherine, Tostanoski, Lisa H, Yu, Jingyou, Gebre, Makda S, Jacob-Dolan, Catherine, Li, Zhenfeng, Patel, Shivani, Peter, Lauren, Liu, Jinyan, Borducchi, Erica N, Nkolola, Joseph P, Souza, Morgana, Tan, Chen Sabrina, Zash, Rebecca, Julg, Boris, Nathavitharana, Ruvandhi R, Shapiro, Roger L, Azim, Ahmed Abdul, Alonso, Carolyn D, Jaegle, Kate, Ansel, Jessica L, Kanjilal, Diane G, Guiney, Caitlin J, Bradshaw, Connor, Tyler, Anna, Makoni, Tatenda, Yanosick, Katherine E, Seaman, Michael S, Lauffenburger, Douglas A, Alter, Galit, Struyf, Frank, Douoguih, Macaya, Van Hoof, Johan, Schuitemaker, Hanneke, Barouch, Dan H
Published in JAMA : the journal of the American Medical Association (20.04.2021)
Published in JAMA : the journal of the American Medical Association (20.04.2021)
Get full text
Journal Article
Pre- and post-Ad26.COV2·S booster dose antibody levels predict COVID-19 disease risk
Roels, Sanne, Bruckner, Matthias, Sadoff, Jerald, Cárdenas, Vicky, Tang, Chan, Hagedoorn, Stefan, Heerwegh, Dirk, Stieh, Daniel J., Le Gars, Mathieu
Published in Vaccine (17.09.2024)
Published in Vaccine (17.09.2024)
Get full text
Journal Article
Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment
Custers, Jerome, Kim, Denny, Leyssen, Maarten, Gurwith, Marc, Tomaka, Frank, Robertson, James, Heijnen, Esther, Condit, Richard, Shukarev, Georgi, Heerwegh, Dirk, van Heesbeen, Roy, Schuitemaker, Hanneke, Douoguih, Macaya, Evans, Eric, Smith, Emily R., Chen, Robert T.
Published in Vaccine (21.05.2021)
Published in Vaccine (21.05.2021)
Get full text
Journal Article
Impact of Preexisting Anti–Adenovirus 26 Humoral Immunity on Immunogenicity of the Ad26.COV2.S Coronavirus Disease 2019 Vaccine
Le Gars, Mathieu, Sadoff, Jerald, Struyf, Frank, Heerwegh, Dirk, Truyers, Carla, Hendriks, Jenny, Gray, Glenda, Grinsztejn, Beatriz, Goepfert, Paul A, Schuitemaker, Hanneke, Douoguih, Macaya
Published in The Journal of infectious diseases (21.09.2022)
Published in The Journal of infectious diseases (21.09.2022)
Get full text
Journal Article
Measuring respiratory syncytial virus infection severity in hospitalized children using the Pediatric Respiratory Syncytial Virus Electronic Severity and Outcome Rating System (PRESORS)
Vandendijck, Yannick, Scott, Jane, Heerwegh, Dirk, Van Der Elst, Wim, Witek, James, Sinha, Rekha, Fennema, Hein
Published in Influenza and other respiratory viruses (01.11.2022)
Published in Influenza and other respiratory viruses (01.11.2022)
Get full text
Journal Article
Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials
Sadoff, Jerald, Le Gars, Mathieu, Brandenburg, Boerries, Cárdenas, Vicky, Shukarev, Georgi, Vaissiere, Nathalie, Heerwegh, Dirk, Truyers, Carla, de Groot, Anne Marit, Jongeneelen, Mandy, Kaszas, Krisztian, Tolboom, Jeroen, Scheper, Gert, Hendriks, Jenny, Ruiz-Guiñazú, Javier, Struyf, Frank, Van Hoof, Johan, Douoguih, Macaya, Schuitemaker, Hanneke
Published in Vaccine (30.07.2022)
Published in Vaccine (30.07.2022)
Get full text
Journal Article
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S as homologous or heterologous COVID-19 booster vaccination: Results of a randomized, double-blind, phase 2 trial
Le Gars, Mathieu, Sadoff, Jerald, Cárdenas, Vicky, Heerwegh, Dirk, Tesfaye, Fisseha, Roey, Griet Van, Spicer, Colleen, Matias, Samantha Santoro, Crayne, Olivia, Kamphuis, Tobias, Struyf, Frank, Schuitemaker, Hanneke, Douoguih, Macaya
Published in Vaccine (25.07.2024)
Published in Vaccine (25.07.2024)
Get full text
Journal Article